• 507
    0

    With the parasite responsible for most malaria cases, Plasmodium falciparum, developing resistance to widely-used treatments, researchers have developed a new drug to fight the mosquito-born disease. Results of a clinical trial published in the journal Lancet Infectious Diseases have shown the drug to be effective against non-severe cases of malaria. The drug, called AQ-13, was ...